Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
1,052 total articles
SAP fell sharply in recent sessions as software names sold off, leaving the stock nearer its 52-week low. Fundamentals remain solid: $246.6B market cap, recurring cloud revenue, and strategic AI-cloud tie-ups. Technicals show oversold conditions and nascent bullish MACD momentum. This is a tactical buying opportunity for a mid-term swing (45 tradin…
Broadcom (AVGO) looks attractively positioned after a recent pullback driven by headline AI CapEx concerns. The company combines high-margin custom silicon, networking gear and sticky infrastructure software, generating $26.9B in free cash flow and a fortress-like ROE of ~28%. With the stock trading near $333.93 and rich multiples priced for perfec…
Interactive Brokers (IBKR) is a capital-efficient, electronically native brokerage that continues to compound earnings via account growth, margin expansion and outsized free cash flow. Trade plan: enter at $74.00, stop $66.00, target $98.00 over a long-term horizon (180 trading days).
Fortress Biotech (FBIO) is a $108M microcap with improving fundamentals, recent non-core asset monetization and enough cash to survive execution risk. The market's focal point is a possible Priority Review Voucher (PRV) pathway tied to legacy assets and recent regulatory developments. If management captures or monetizes a PRV, the stock can reprice…
Wendy's plunged on execution worries and a messy reset, but the business still throws off meaningful free cash flow (FCF $237.8M) and trades at single-digit earnings multiples (P/E ~9.6, EV/EBITDA ~8.5). With activist Trian pushing for value-creating options and the stock sitting near its 52-week low ($6.73), the risk/reward favors a long trade her…
eBay's acquisition of Depop, stronger-than-expected Q4 results and a $2B buyback authorization make the stock attractive around $85. The business is producing solid free cash flow ($1.53B), GMV is expanding ($21.2B), and management is targeting younger buyers via Depop - a catalyst that should re-rate the multiple. My swing trade: buy $85, stop $78…
Provident Financial Services (PFS) has already rallied from its 52-week low to trade near $23, but earnings, a 4%+ yield, and a fresh buyback authorization give the stock a concrete path to further gains. This trade idea lays out an entry at $22.95, a stop at $21.00 and a target at $27.50 for a mid-term push over roughly 45 trading days.
Sunoco L.P. is positioned to grow its distribution at least 5% in 2026 backed by $600M+ growth capex and $3.1-$3.3B adjusted EBITDA guidance. Valuation is reasonable with a $9.81B market cap, $17.79B enterprise value and an EV/EBITDA of ~11.1. I recommend a long trade to capture distribution and re-rating potential, with tight risk controls to navi…
SAP has been dragged down in a broad software sell-off, trading near $200 with technically oversold conditions and elevated short activity. The company’s $246.6B market cap, strategic AI partnerships, and still-resilient fundamentals make a mid-term long a reasonable tactical trade. Entry $198.00, stop $188.00, target $230.00 for a mid-term (45 tra…
Amazon trades at $204.91 with a $2.27 trillion market cap and clear near-term pain from heavy capex and political scrutiny. Still, AWS is back to its fastest growth in 13 quarters and AI is primed to multiply margins across cloud, advertising and logistics. This trade buys a pullback with a defined stop and a 180‑day timeframe to capture an AI-driv…
Intuit (INTU) has been slammed alongside the software sector on fears that new AI agents will erase subscription economics. The stock is trading near its 52-week low after a 50% fall from the 52-week high, but the company still generates strong free cash flow ($6.39B), has a healthy balance sheet and high incremental profitability. This trade idea …
Bristol-Myers posted a strong quarter and raised 2026 guidance, driven by a 16% surge in its Growth Portfolio. With a market cap near $123B, a 4.17% yield, and free cash flow north of $12.8B, BMY offers an attractive combination of yield and upside. I initiate a long trade at $60.30, with a $56 stop and a $66 target over a staged 180-trading-day pl…
Sunoco (SUN) posted results and guidance that give the distribution and cash-flow story renewed credibility. With adjusted EBITDA guidance, a 5% distribution growth target, and a clean free-cash-flow print of $373M, the setup is actionable: enter $62.00, place a protective stop at $58.00, and target $70.00 over the next 180 trading days. Momentum t…
DoorDash trades well below its 52-week high after a Q4 miss, but the platform's high-frequency demand, expanding logistics palette, and early AI deployments create a path to margin expansion and higher lifetime value. This trade idea buys near current levels with a tight stop and a mid-term target that prices in partial multiple recovery tied to ex…
Workday has been punished on leadership noise and macro-driven tech selling. Fundamentals - including $2.59B in free cash flow, a manageable balance sheet and large enterprise footprint - argue the selloff is excessive. Technical overshoot (RSI ~21) and heavy short activity create a high-reward swing trade. Entry at $140.02, stop $132.00, target $2…
Microsoft has been punished in 2026 as the market frets about heavy AI-related capex, softer Azure growth, and slow Copilot adoption. Fundamentals remain strong: $77.4B free cash flow, 30% return on equity, and a $2.95T market cap. Technicals show near-oversold conditions and compressing momentum. This trade idea outlines an actionable long trade w…
Reaves Utility Income Fund (UTG) looks oversold relative to its yield and current momentum. Price at $40.12 sits well above the April 2025 low and shows rising SMAs and a bullish MACD. With a dividend payable 03/31/2026 and ex-dividend 03/18/2026 plus a compact share count and $3.5B market cap, this is a tactical long with defined risk/reward.
FactSet has been swept up in a broader 'AI-phobia' rotation that punished legacy data and software names. The business still generates strong cash flow ($647M FCF), sports a healthy ROE (27.7%) and carries a modest leverage profile (debt/equity 0.63). At roughly $7.38B market cap and a P/E near 12-12.6, the stock offers a favorable risk/reward for …
Ezcorp (EZPW) combines steady pawn-loan economics, a string of accretive acquisitions, and healthy free cash flow into a valuation that still looks reasonable. After closing a major roll-up that adds 105 stores and $147M of revenue, the company offers a mid-to-long-term trade with clear entry, target and stop rules to capture upside while limiting …
T‑Mobile reported better-than-expected Q4 results and gave 2026 free cash flow guidance of $18.0-18.7 billion. The name pulled back to near $215 after a volatile start to the year; technicals and short-interest dynamics favor a rebound. This trade idea lays out an actionable entry at the current level, a stop under the 50-day moving average, and a …
The market has confused cyclical hardware noise with a durable margin collapse. Dell's mix of installed enterprise customers, meaningful free cash flow ($4.45B), and a sub-1x EV/sales valuation create a clear asymmetric trade. Entry at $118.50, stop $98.00, target $178.00 - long term (180 trading days).
Elliott Investment Management's disclosed 10%+ stake and activist campaign is a high-probability catalyst for Norwegian Cruise Line (NCLH). The firm trades at an attractive EV/EBITDA and P/E relative to potential upside if SG&A and capital allocation are tightened. This trade targets a re-rating to the $28 area over a mid-term horizon while keeping…
Catalyst Pharmaceuticals is a commercial-stage rare-disease specialty drug company with clear levers to grow revenue from its FDA-approved portfolio. Recent regulatory wins and a patent settlement that delays broad generic entry create a multi-quarter runway. Valuation is reasonable relative to cash generation; this trade targets upside to $32 with…
Meta’s core advertising business remains cash-generative while AI and new hardware initiatives are reaccelerating growth. Market sentiment is tepid, technicals show short-term fatigue, and headline sellers have pressured the stock below its recent trading averages. That combination creates an asymmetric trade: overweight risk-reward with a clear st…
Bristol-Myers Squibb's oncology franchise and data-rich 2026 give the company a near-term bull case. The stock trades at roughly $59.71 with a market cap near $122B, supported by a high-margin growth portfolio, solid free cash flow and a 4%+ dividend. We outline a mid-term long trade (45 trading days) to capture upside around clinical and commercia…
